Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 11, 2012, Pages

  Park, Min Chul ^a   Kang, Taehee ^a   Jin, Da ^a   Han, Jung Min ^a   Kim, Sang Bum ^a   Park, Yun Jung ^b   Cho, Kiwon ^b   Park, Young Woo ^b   Guo, Min ^c   He, Weiwei ^d   Yang, Xiang Lei ^d   Schimmel, Paul ^d   Kim, Sunghoon ^a  

^a Seoul National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cancer microenvironment; Cytokine; Immune surveillance; Proapoptotic effect

Indexed keywords

CADHERIN; FAS LIGAND; GLYCINE TRANSFER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; DEPHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; SERUM;

ANIMALS; APOPTOSIS; CADHERINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FAS LIGAND PROTEIN; GLYCINE-TRNA LIGASE; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, CELL SURFACE; STRESS, PHYSIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863251058     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1200194109     Document Type: Article

References (51)

1. Ibba M, Soll D (2000) Aminoacyl-tRNA synthesis. Annu Rev Biochem 69:617-650.
2. Kämper U, Kück U, Cherniack AD, Lambowitz AM (1992) The mitochondrial tyrosyl-tRNA synthetase of Podospora anserina is a bifunctional enzyme active in protein synthesis and RNA splicing. Mol Cell Biol 12:499-511.
3. Park SG, Ewalt KL, Kim S (2005) Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: New perspectives on housekeepers. Trends Biochem Sci 30:569-574. (Pubitemid 41356495)
4. Guo M, Schimmel P, Yang X-L (2010) Functional expansion of human tRNA synthetases achieved by structural inventions. FEBS Lett 584:434-442.
5. Park SG, Schimmel P, Kim S (2008) Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci USA 105:11043-11049.
6. Sampath P, et al. (2004) Noncanonical function of glutamyl-prolyl-tRNA synthetase: Gene-specific silencing of translation. Cell 119:195-208. (Pubitemid 39360902)
7. Jordanova A, et al. (2006) Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38:197-202. (Pubitemid 43177233)
8. Nangle LA, Zhang W, Xie W, Yang X-L, Schimmel P (2007) Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Natl Acad Sci USA 104:11239-11244. (Pubitemid 47175125)
9. Wakasugi K, Schimmel P (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284:147-151. (Pubitemid 29282068)
10. Zhou Q, et al. (2010) Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality. Nat Struct Mol Biol 17:57-61.
11. Wakasugi K, et al. (2002) A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Natl Acad Sci USA 99:173-177. (Pubitemid 34060336)
12. Yang X-L, et al. (2007) Functional and crystal structure analysis of active site adaptations of a potent anti-angiogenic human tRNA synthetase. Structure 15: 793-805. (Pubitemid 47049681)
13. Mathews MB, Bernstein RM (1983) Myositis autoantibody inhibits histidyl-tRNA synthetase: A model for autoimmunity. Nature 304:177-179. (Pubitemid 13079148)
14. Mathews MB, Reichlin M, Hughes GR, Bernstein RM (1984) Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 160:420-434. (Pubitemid 14052507)
15. Stojanov L, Satoh M, Hirakata M, Reeves WH (1996) Correlation of antisynthetase antibody levels with disease course in a patient with interstitial lung disease and elevated muscle enzymes. J Clin Rheumatol 2:89-95.
16. Howard OM, et al. (2002) Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 196:781-791.
17. Mun J, et al. (2010) A proteomic approach based on multiple parallel separation for the unambiguous identification of an antibody cognate antigen. Electrophoresis 31: 3428-3436.
18. Carruba G, et al. (2003) Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J Cell Biochem 90:187-196. (Pubitemid 37052320)
19. Witsell AL, Schook LB (1992) Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation. Proc Natl Acad Sci USA 89:4754-4758.
20. Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS (2007) Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 110:3234-3244. (Pubitemid 350106316)
21. Khodarev NN, et al. (2003) Tumour-endothelium interactions in co-culture: Coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 116:1013-1022. (Pubitemid 36395612)
22. Igney FH, Krammer PH (2002) Immune escape of tumors: Apoptosis resistance and tumor counterattack. J Leukoc Biol 71:907-920.
23. Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig- CAMs in cancer. Nat Rev Cancer 4:118-132. (Pubitemid 38198740)
24. Shimazui T, et al. (1998) Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma. Clin Cancer Res 4: 2419-2424. (Pubitemid 28477907)
25. Shimoyama Y, Gotoh M, Terasaki T, Kitajima M, Hirohashi S (1995) Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells. Cancer Res 55:2206-2211.
26. Anjum R, Blenis J (2008) The RSK family of kinases: Emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9:747-758.
27. Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26:3291-3310. (Pubitemid 46763022)
28. Keyse SM (2000) Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12:186-192.
29. Wang PY, Liu P, Weng J, Sontag E, Anderson RG (2003) A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity. EMBO J 22: 2658-2667. (Pubitemid 36712363)
30. Chen J, Martin BL, Brautigan DL (1992) Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257:1261-1264.
31. Janssens V, Goris J (2001) Protein phosphatase 2A: A highly regulated family of serine/threonine phophatases implicated in cell growth and signalling. Biochem J 53: 417-439. (Pubitemid 32158309)
32. Seburn KL, Nangle LA, Cox GA, Schimmel P, Burgess RW (2006) An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 51:715-726. (Pubitemid 44374911)
33. Motley WW, Talbot K, Fischbeck KH (2010) GARS axonopathy: Not every neuron's cup of tRNA. Trends Neurosci 33:59-66.
34. Raben N, et al. (1994) A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. J Biol Chem 269: 24277-24283.
35. Swann JB, Smyth MJ (2007) Immune surveillance of tumors. J Clin Invest 117: 1137-1146. (Pubitemid 46718398)
36. Trinchieri G (1995) Natural killer cells wear different hats: Effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin Immunol 7:83-88.
37. Almasan A, Ashkenazi A (2003) Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14:337-348. (Pubitemid 36693152)
38. Luo J-L, Maeda S, Hsu L-C, Yagita H, Karin M (2004) Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6:297-305. (Pubitemid 39222042)
39. Bos JL (1989) ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689.
40. Lange-Carter CA, Johnson GL (1994) Ras-dependent growth factor regulation of MEK kincase in PC12 cells. Science 2:1458-1461. (Pubitemid 24306801)
41. Scandurro AB, Weldon CW, Figueroa YG, Alam J, Beckman BS (2001) Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol 19:129-135.
42. Laakko T, Juliano RL (2003) Adhesion regulation of stromal cell-derived factor-1 activation of ERK in lymphocytes by phosphatases. J Biol Chem 278:31621-31628. (Pubitemid 37048340)
43. Mitsushima M, Ueda K, Kioka N (2007) Involvement of phosphatases in the anchorage-dependent regulation of ERK2 activation. Exp Cell Res 313:1830-1838. (Pubitemid 46653873)
44. Hill E, Broadbent ID, Chothia C, Pettitt J (2001) Cadherin superfamily proteins in Caenorhabditis elegans and Drosophila melanogaster. J Mol Biol 305:1011-1024. (Pubitemid 33027739)
45. Pettitt J (2005) The cadherin superfamily. WormBook 29:1-9.
46. Guo M, Yang X-L, Schimmel P (2010) New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol 11:668-674.
47. Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335: 865-875.
48. Fujita J, et al. (1988) Activated H-ras oncogenes in human kidney tumors. Cancer Res 48:5251-5255.
49. Stumm G, et al. (1996) Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis. Int J Cancer 69:17-22. (Pubitemid 26083265)
50. Aisner J (1996) Extensive-disease small-cell lung cancer: The thrill of victory; the agony of defeat. J Clin Oncol 14:658-665.
51. Sethi T, et al. (1999) Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 5:662-668. (Pubitemid 29289430)